Recruiting NA INTERVENTIONAL 2-arm NCT04331769

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Sponsor: Ancora Heart, Inc.

Conditions Dilated Cardiomyopathy Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions AccuCinch Ventricular Restoration System Guideline-Directed Medical Therapy

Updated 30 times since 2020 Last updated: Dec 5, 2025 Started: Dec 21, 2020 Primary completion: Dec 31, 2026 Completion: Dec 21, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Dilated Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (HFrEF) and is currently actively recruiting participants. Ancora Heart, Inc. leads this study, which shows 30 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

30 versions recorded

Jan 2026 — Present [monthly]

Recruiting NA
Sep 2025 — Jan 2026 [monthly]

Recruiting NA
Jul 2025 — Sep 2025 [monthly]

Recruiting NA
Dec 2024 — Jul 2025 [monthly]

Recruiting NA
Nov 2024 — Dec 2024 [monthly]

Recruiting NA

▶ Show 25 earlier versions

Sep 2024 — Nov 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Recruiting NA
Mar 2024 — Apr 2024 [monthly]

Recruiting NA
Feb 2024 — Mar 2024 [monthly]

Recruiting NA
Jan 2024 — Feb 2024 [monthly]

Recruiting NA
Dec 2023 — Jan 2024 [monthly]

Recruiting NA
Nov 2023 — Dec 2023 [monthly]

Recruiting NA
May 2023 — Nov 2023 [monthly]

Recruiting NA
Dec 2022 — May 2023 [monthly]

Recruiting NA
Sep 2022 — Dec 2022 [monthly]

Recruiting NA
May 2022 — Sep 2022 [monthly]

Recruiting NA
Apr 2022 — May 2022 [monthly]

Recruiting NA
Jan 2022 — Apr 2022 [monthly]

Recruiting NA
Dec 2021 — Jan 2022 [monthly]

Recruiting NA
Nov 2021 — Dec 2021 [monthly]

Recruiting NA
Oct 2021 — Nov 2021 [monthly]

Recruiting NA
Sep 2021 — Oct 2021 [monthly]

Recruiting NA
Mar 2021 — Sep 2021 [monthly]

Recruiting NA
Feb 2021 — Mar 2021 [monthly]

Recruiting NA
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Oct 2020 — Dec 2020 [monthly]

Not Yet Recruiting NA
Jul 2020 — Oct 2020 [monthly]

Not Yet Recruiting NA

Status: Withheld → Not Yet Recruiting · Phase: None → NA
May 2020 — Jul 2020 [monthly]

Withheld

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ancora Heart, Inc.

Data source: Ancora Heart, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalst, Belgium , Albuquerque, United States , Ann Arbor, United States , Athens, Greece , Atlanta, United States , Atlantis, United States , Aurora, United States , Austin, United States , Baltimore, United States , Bangor, United States and 94 more locations